Archive for the ‘Scientific Meetings & Publications’ Category
May 24, 2025 — In BMJ Public Health, Annabel Davies and colleagues have published a new analysis of interventions to prevent obesity in children. They started with data from two Cochrane systematic reviews published in 2024 (here and here) and applied a Bayesian multi-level meta-regression analysis. What they found were obesity prevention effects that range from being small and […]
May 21, 2025 — We do not think for a minute that Lilly or Novo Nordisk will be pursuing any sort of mental health indication for semaglutide or tirzepatide. But it increasingly appears that the effect of GLP-1 use for either diabetes or obesity is more positive than negative for mental health. A new systematic review and meta-analysis in […]
May 20, 2025 — A new viewpoint in JAMA Pediatrics articulates a concern we hear repeatedly about the Lancet Commission on Clinical Obesity. Pediatric obesity experts have reservations about applying the concept of preclinical obesity in pediatrics. Melania Manco is a professor of pediatrics, clinical research scientist, and consultant endocrinologist at the Bambino Gesù Hospital in Rome. She writes: […]
May 19, 2025 — Obesity care is in the midst of an awkward but critical transition. Standards of care for obesity are leaking out from specialists in obesity medicine through a process of translation to the setting of primary care for the masses. Primary care for obesity will draw upon the authoritative work of organizations like Obesity Canada, The […]
May 17, 2025 — This should not be so hard. But apparently it is very hard for people to accept, in their hearts, that the disease of obesity is actually chronic. Yes, people will repeat the words that experts and thought leaders have fed them. “It is undeniable that obesity is a complex, chronic disease.” So says the International […]
May 16, 2025 — This week the European Congress on Obesity drew spectacular crowds. Of course, hanging in there for the final day of any congress is a challenge, but the closing day of ECO2025 rewarded stalwarts with excellent insights into the promise of precision obesity medicine. The Genetic Contribution to Obesity Although it was not intended as a […]
May 14, 2025 — New studies released yesterday at ECO2025 remind us doctors and other health professionals often miss things that are quite obvious to people living with obesity. For one thing, there is the phenomenon of food noise. It’s very real for many people with obesity. For health professionals, it can seem a bit abstract. Then there is […]
May 13, 2025 — At ECO2025 today, a new analysis from the landmark SELECT trial reveals that heart health benefits with semaglutide can start early for people with obesity and pre-existing heart disease. Within just three months, semaglutide reduced the risk of major cardiovascular events (MACE) by 38% compared to placebo. By six months, this risk dropped by 41%. […]
May 12, 2025 — This is quite a day for the folks who have invested energy and others who have invested a great deal of money into developing tirzepatide for obesity. They took the risk of doing a head-to-head study of this drug against semaglutide and it clearly paid off. In the SURMOUNT-5 study, tirzepatide came out ahead on […]
May 11, 2025 — ECO2025 in Málaga, Spain, today (Sunday) started off with a sweeping review of weight bias, obesity stigma, and strategies for ending them. It’s a big ambition. But it was an honor for ConscienHealth to participate with an array of experts in the subject. The thought to take away from it is simply that progress is […]